What have we learned after four randomized controlled trials on neoadjuvant chemotherapy for ovarian cancer? | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

other Versions

You are currently viewing an earlier version of this article (April 01, 2021).
View the most recent version of this article

Commentary

What have we learned after four randomized controlled trials on neoadjuvant chemotherapy for ovarian cancer?

Online download statistics by month:

Online download statistics by month: December 2020 to April 2024

	Abstract	Full	Pdf
Dec 2020	0	26	18
Jan 2021	0	62	36
Feb 2021	0	14	13
Mar 2021	0	10	6
Apr 2021	0	41	26
May 2021	0	5	4
Jun 2021	0	3	5
Jul 2021	0	1	2
Aug 2021	0	2	3
Sep 2021	0	3	2
Oct 2021	0	1	0
Nov 2021	0	0	1
Jan 2022	0	2	1
Feb 2022	0	2	0
Mar 2022	0	5	3
Apr 2022	0	0	1
May 2022	0	1	1
Jun 2022	0	1	1
Jul 2022	0	2	1
Oct 2022	0	1	0
Nov 2022	0	11	9
Dec 2022	0	1	1
Jan 2023	0	5	1
Apr 2023	0	1	1
May 2023	0	1	1
Sep 2023	0	1	3
Oct 2023	0	0	1
Jan 2024	0	2	1
Feb 2024	0	1	0
Apr 2024	0	1	1
Total	0	206	143